AbbVie · 2 weeks ago
Senior Cyber Threat Researcher (Remote)
United States
Full-time
Remote
Senior Level
$106K/yr - $202K/yr
6+ years expAbbVie is a company dedicated to discovering and delivering innovative medicines and solutions for serious health issues. They are seeking a Senior Cyber Threat Researcher to lead their Cyber Threat Intelligence team, focusing on producing actionable intelligence and overseeing the threat hunting service.
BiotechnologyFinancial ServicesHealth CareMedicalPharmaceuticalVenture Capital
Responsibilities
Discover, collect, analyze, and model cyber intrusion campaigns using internal security data, case investigations, and sourced intelligence
Research, produce, and deliver finished intelligence products and threat briefings to diverse audiences—including technical teams, business units, and senior executives—to inform tactical operations and strategic security planning
Develop and enhance capabilities for understanding adversary tools, tactics, and evolving infrastructure
Provide direct oversight, ownership, and continual maturation of the threat hunting service: Develop service methodologies, set execution standards, and provide guidance and mentorship for full-time and part-time threat hunters; drive cross-functional and crowdsourced hunt initiatives; ensure intelligence-driven prioritization of hunt activities
Identify and recommend defensive improvements based on observations and insights from both threat intelligence and hunt activities
Qualification
Required
Bachelor's Degree with 7 years experience; Master's Degree with 6 years experience; PhD with 2 years experience
Experience in application program development
Work experience should be in cyber security disciplines
Strong background in cybersecurity, with significant time in cyber threat intelligence and additional experience in fields such as incident response, forensics, detection engineering, or CSIRT operations
5+ years in roles such as Intrusion Detection, Incident Response, Cyber Threat Intelligence, or similar security disciplines
Strong familiarity with standard threat frameworks (e.g., MITRE ATT&CK, Cyber Kill Chain), and hands-on experience analyzing adversary tactics, techniques, and procedures (TTPs)
Proficiency in creating detective content (e.g., SIEM correlation rules, Snort/YARA signatures) and supporting the deployment of these assets with technical teams
Capable of conducting static and dynamic malware analysis, as well as interacting with outputs from common malware analysis tools
Scripting skills (e.g., Python, PowerShell) for automation, enrichment, and analysis
Experience analyzing event data from a variety of security controls (firewalls, IPS/IDS, endpoint/AV/EDR, network analyzers) and enterprise log management platforms
Ability to recognize and communicate limitations or gaps in data collection (e.g., missing or unparsed log sources)
Exceptional written and verbal communication skills; adept at condensing complex technical or threat information into actionable briefs and updates tailored for strategic, operational, and tactical audiences
Benefits
Paid time off (vacation, holidays, sick)
Medical/dental/vision insurance
401(k)
Short-term incentive programs
Company
AbbVie
AbbVie is a biopharmaceutical company focused on immunology, oncology, neuroscience, virology, and aesthetics. It is a sub-organization of AbbVie.
10001+ employees
H1B Sponsorship
AbbVie has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (273)
2024 (190)
2023 (225)
2022 (284)
2021 (186)
2020 (186)
Funding
Current Stage
Public CompanyTotal Funding
$15B2024-02-27Post Ipo Debt· $15B
2023-03-08Post Ipo Equity· $0.25M
2012-12-20IPO
Leadership Team
Robert Michael
Chairman of the Board and Chief Executive Officer
Micah Bregman
Vice President, Global Strategy and Pipeline, Allergan Aesthetics
Recent News
2026-01-23
2026-01-20
2026-01-20
Company data provided by crunchbase